|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Deferred income taxes | |||||
| Impairment of majority-owned foreign subsidiaries | |||||
| Amortization of marketable security premiums and discounts, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Other receivables | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Income taxes payable | |||||
| Postretirement health care benefits | |||||
| Deferred compensation and other liabilities | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Capital expenditures | |||||
| Purchases of trading securities | |||||
| Sales of trading securities | |||||
| Purchase of available for sale securities | |||||
| Sale and maturity of available for sale securities | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Shares purchased and retired | |||||
| Dividends paid in cash | |||||
| Proceeds from bank loans | |||||
| Repayment of bank loans | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental cash flow information: | |||||
| Income taxes paid, net | |||||
| Interest paid | |||||
| Stock dividend issued | |||||
Loading...